Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational
This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indica
| Condition(s) | Renal Tumors |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy. |
| Who can participate | Inclusion Criteria: * Presence of a renal mass up to 4 cm * Adult \> 18 years * Candidate to renal surgery * Informed consent signed Exclusion Criteria: * Contraindication for MRI |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | IRCCS San Raffaele |
| Locations | Milan, Italia, Italy |
| Start date | 2025-09-26 |
| NCT ID | NCT06868927 |
| Official listing | https://clinicaltrials.gov/study/NCT06868927 |